يعرض 1 - 10 نتائج من 10 نتيجة بحث عن '"NAAT, nucleic acid amplification test"', وقت الاستعلام: 0.43s تنقيح النتائج
  1. 1
    Academic Journal

    المصدر: Indian Journal of Microbiology Research 4(1):7-13. 2017

  2. 2
  3. 3

    المصدر: International Journal of Infectious Diseases
    International Journal of Infectious Diseases, Vol 105, Iss, Pp 632-638 (2021)

    مصطلحات موضوعية: Male, 0301 basic medicine, ECLIA, Electrochemiluminescence immunoassay, CLIA, Chemiluminescent immunoassay, Prevalence, Diagnostic Specificity, Infectious and parasitic diseases, RC109-216, Validation Studies as Topic, Antibodies, Viral, 0302 clinical medicine, Germany, LoB, Limit of blank, Validation, SD, Standard deviation, 030212 general & internal medicine, Serological assay, Immunoassay, COVID-19, Coronavirus disease 2019, education.field_of_study, medicine.diagnostic_test, General Medicine, Middle Aged, ELISA, Enzyme-linked immunosorbent assay, Infectious Diseases, Anti-SARS-CoV-2, Population study, Female, Microbiology (medical), medicine.medical_specialty, CE, Conformité Européenne, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), 030106 microbiology, Population, NAT, Neutralizing antibody test, Sensitivity and Specificity, Article, WHO, World Health Organization, COVID-19 Serological Testing, EUA, Emergency use authorization, 03 medical and health sciences, Predictive Value of Tests, EU, European Union, Intensive care, medicine, Humans, NAAT, Nucleic acid amplification test, education, COI, Cutoff index, CV, Coefficient of variation, Aged, Retrospective Studies, Roche, SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2, SARS-CoV-2, ICD-10, International Statistical Classification of Diseases and Related Health Problems, business.industry, qRT-PCR, Quantitative reverse transcriptase polymerase chain reaction, Disease progression, LoD, Limit of detection, Verification, Reproducibility of Results, CLSI, Clinical and Laboratory Standards Institute, COVID-19, FDA, Food and Drug Administration, Emergency medicine, Laboratories, business

  4. 4

    المصدر: EBioMedicine, Vol 75, Iss, Pp 103788-(2022)
    EBioMedicine

  5. 5

    المساهمون: HPV Prevention Control Board, International Papillomavirus Society IPVS, HPV Prevention and Control Board and the International Papillomavirus Society (IPVS), University of Antwerp, Institut Català d'Oncologia, University of Ljubljana, University of Cambridge, University of Melbourne, Universitat Oberta de Catalunya

    المصدر: Preventive Medicine
    Preventive medicine
    O2, repositorio institucional de la UOC
    Universitat Oberta de Catalunya (UOC)

    وصف الملف: application/pdf

  6. 6
  7. 7
  8. 8

    المساهمون: Doctoral Programme in Biomedicine, Research Programs Unit, Immunomics, Immunobiology Research Program, Department of Medical and Clinical Genetics, Medicum, University of Helsinki

    المصدر: Diagnostic Microbiology and Infectious Disease

  9. 9

    المصدر: Diagnostic Microbiology and Infectious Disease

  10. 10

    المصدر: Molecular & Cellular Proteomics : MCP